Evolve Biologics
Britney Snaith has a diverse work experience history. In 2019, they began their career at Thermo Fisher Scientific, where they held two roles. First, they worked as a Quality Control Analyst I, Raw Materials from August 2019 to September 2021. Then, they transitioned to the role of Scientist I, Analytical Operations from September 2021 to August 2022. In 2021, Britney briefly worked as a Cosmetic Research Consultant from April to September. Currently, they are employed at Evolve Biologics as a Project Coordinator as of August 2022. Additionally, in 2019, Britney worked at the Workplace Safety and Insurance Board as a Customer Service Representative/Travel Assistant from April to August.
Britney Snaith completed their Bachelor of Science (B.Sc.) degree in Biochemistry and Molecular Biology at the University of Toronto from 2014 to 2019. In addition to their degree, they obtained various certifications, including an MBA Essentials certificate from the University of Toronto - Rotman School of Management in March 2023, a Programming for Everybody (Getting Started with Python) certificate from Coursera in February 2021, a DELF B1 certificate from the French Ministry for National Education in December 2020, and a WHMIS (Workplace Hazardous Materials Information System) certificate from the University of Toronto in January 2015.
This person is not in any teams
Evolve Biologics
Evolve Biologics Inc. offers the development and commercialization of plasma-derived therapeutics, using its proprietary PlasmaCap EBA purification technology to more efficiently and effectively meet growing global patient demand for these life-saving products. The Company is currently in the process of commercializing an exciting and innovativeportfolio of product candidates, including IVIG (intravenous immunoglobulin) and Albumin (human serum albumin), both of which are in advanced stages of regulatory approval in the US (FDA) and Canada (Health Canada).